Invex Total Assets from 2010 to 2024

Stocks . Australia . 
Stock . Invex Therapeutics
IXC Stock   0.07  0.01  7.46%   
Invex Therapeutics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 5.8 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2019-03-31
Previous Quarter
6.3 M
Current Value
6.1 M
Quarterly Volatility
10.6 M
 
Covid
Check Invex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Invex Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 3.8 M or Interest Expense of 96.5 K, as well as many indicators such as . Invex financial statements analysis is a perfect complement when working with Invex Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Invex Therapeutics Technical models . Check out the analysis of Invex Therapeutics Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Invex Stock Analysis

When running Invex Therapeutics' price analysis, check to measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY